Stage-Aware and Explainable Machine Learning for Predicting IVF Implantation

The study suggests that IVF implantation prediction accuracy increases with later-stage treatment information, particularly embryological data.

Summary and findings

This study developed a machine-learning framework to predict implantation outcomes in IVF using a public dataset. β-HCG was excluded to avoid potential leakage, and several models were optimized and evaluated. The findings indicate that predictive performance improves with additional treatment-related information, particularly embryological variables.

Abstract

Predicting implantation outcomes in vitro fertilization (IVF) is challenging because clinically relevant information becomes available at different points during treatment. In this study, we developed a stage-aware, leakage-conscious, and explainable machine-learning framework to predict implantation using a public IVF dataset. β-HCG was excluded to avoid potential downstream target leakage. The data were divided into training, validation, and independent test sets. Several machine-learning models, including Logistic Regression, Random Forest (RF), Extra Trees, XGBoost, and Hist Gradient Boosting, were optimized using stratified cross-validation. A fixed RF model was then evaluated at three stages of the IVF process, using baseline couple characteristics, gamete and fertilization variables, and embryological variables, respectively. Model performance improved as additional treatment-related information became available, with the largest improvement observed after the inclusion of embryological variables. The final RF model showed good predictive performance on the independent test set. The number of embryos was consistently identified as the most important predictor across RF, permutation, and SHAP analyses. Overall, the findings suggest that IVF implantation prediction becomes more accurate as later-stage treatment information is incorporated, particularly information related to embryological characteristics. The proposed approach also provides interpretable predictions while reducing the risk of information leakage. Further evaluation using independent clinical datasets is needed before the framework can be considered for clinical use.

Limitations

Not reported in abstract.

Elsewhere in the HCG (Human Chorionic Gonadotropin) corpus